BR9812780A - 2-aril-3-aroilbenzo[b]tiofenos úteis para o tratamento de sìndrome da perda de estrogênio - Google Patents

2-aril-3-aroilbenzo[b]tiofenos úteis para o tratamento de sìndrome da perda de estrogênio

Info

Publication number
BR9812780A
BR9812780A BR9812780-2A BR9812780A BR9812780A BR 9812780 A BR9812780 A BR 9812780A BR 9812780 A BR9812780 A BR 9812780A BR 9812780 A BR9812780 A BR 9812780A
Authority
BR
Brazil
Prior art keywords
aryl
treatment
aroilbenzo
loss syndrome
estrogen loss
Prior art date
Application number
BR9812780-2A
Other languages
English (en)
Inventor
George Jopseph Cullinan
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of BR9812780A publication Critical patent/BR9812780A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Patente de Invenção: <B>"2-ARIL-3-AROILBENZO[b]TIOFENOS úTEIS PARA O TRATAMENTO DE SìNDROME DA PERDA DE ESTROGêNIO"<D>. A invenção refere-se a métodos que são úteis para a inibição das várias condições médicas associadas a síndrome da perda de estrogênio, incluindo osteoporose e hiperlipidemia, métodos estes que utilizam compostos de fórmula (I).
BR9812780-2A 1997-11-14 1998-11-09 2-aril-3-aroilbenzo[b]tiofenos úteis para o tratamento de sìndrome da perda de estrogênio BR9812780A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6585297P 1997-11-14 1997-11-14
PCT/US1998/023712 WO1999025706A1 (en) 1997-11-14 1998-11-09 2-aryl-3-aroylbenzo[b]thiophenes useful for the treatment of estrogen deprivation syndrome

Publications (1)

Publication Number Publication Date
BR9812780A true BR9812780A (pt) 2000-10-03

Family

ID=22065569

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9812780-2A BR9812780A (pt) 1997-11-14 1998-11-09 2-aril-3-aroilbenzo[b]tiofenos úteis para o tratamento de sìndrome da perda de estrogênio

Country Status (21)

Country Link
US (2) US6156786A (pt)
EP (1) EP0920863B1 (pt)
JP (1) JP2001523675A (pt)
KR (1) KR20010031904A (pt)
CN (1) CN1278812A (pt)
AT (1) ATE244565T1 (pt)
AU (1) AU748394B2 (pt)
BR (1) BR9812780A (pt)
CA (1) CA2309824A1 (pt)
DE (1) DE69816244D1 (pt)
EA (1) EA200000520A1 (pt)
HR (1) HRP20000287A2 (pt)
HU (1) HUP0004413A3 (pt)
ID (1) ID24978A (pt)
IL (1) IL135509A0 (pt)
NO (1) NO20002370L (pt)
NZ (1) NZ503990A (pt)
PL (1) PL340432A1 (pt)
TR (1) TR200001290T2 (pt)
WO (1) WO1999025706A1 (pt)
ZA (1) ZA9810215B (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE39049E1 (en) 1992-07-28 2006-03-28 Eli Lilly And Company Methods for inhibiting bone loss
USRE38968E1 (en) 1992-07-28 2006-02-07 Eli Lilly And Company Methods for inhibiting bone loss using 6-hydroxy-2-(4-hydroxyphenyl)-benzo[b]thien-3-yl-4-[2-(piperidin-1-yl) ethoxyphenylimethanone hydrochloride
TW366342B (en) 1992-07-28 1999-08-11 Lilly Co Eli The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss
US5478847A (en) 1994-03-02 1995-12-26 Eli Lilly And Company Methods of use for inhibiting bone loss and lowering serum cholesterol
US6096781A (en) * 1997-11-14 2000-08-01 Eli Lilly And Company 2-arylbenzo[B]thiophenes useful for the treatment of estrogen deprivation syndrome
ID24978A (id) * 1997-11-14 2000-08-31 Lilly Co Eli 2-ARYL-3-AROYLBENZO (b) THIOPHENES BERGUNA UNTUK PENGOBATAN SINDROM DEPRIVASI ESTROGEN
US6258826B1 (en) 1998-10-13 2001-07-10 Eli Lilly And Company Pharmaceutical formulations and applications thereof for the treatment of estrogen deprivation syndrome
AU7896100A (en) * 1999-10-14 2001-04-23 Endorecherche Inc. Selective estrogen receptor modulators in the treatment or reduction of the riskof acquiring hypertension, cardiovascular diseases, and insulin resistance
US20060106010A1 (en) * 2003-05-27 2006-05-18 Black Larry J Methods for inhibiting bone loss
WO2011132194A1 (en) * 2010-04-19 2011-10-27 Hetero Research Foundation Process for the preparation of raloxifene hydrochloride
ES2774935T3 (es) 2012-10-24 2020-07-23 Univ Illinois Composiciones y métodos para tratar trastornos médicos relacionados con estrógeno
EP3192795B1 (en) 2012-10-24 2020-12-02 The Board of Trustees of the University of Illionis Compositions and methods for treating estrogen-related medical disorders

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4133814A (en) * 1975-10-28 1979-01-09 Eli Lilly And Company 2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents
US4418068A (en) * 1981-04-03 1983-11-29 Eli Lilly And Company Antiestrogenic and antiandrugenic benzothiophenes
TW366342B (en) * 1992-07-28 1999-08-11 Lilly Co Eli The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss
SG90193A1 (en) * 1995-02-28 2002-07-23 Lilly Co Eli Benzothiophene compounds, intermediates, compositions, and methods
US5532382A (en) * 1995-03-13 1996-07-02 Eli Lilly And Company Benzothiophenes substituted at the 3-carbonyl
US5514703A (en) * 1995-03-13 1996-05-07 Eli Lilly And Company Benzothiophene compounds useful for inhibiting lipoxygenase
US5514704A (en) * 1995-03-13 1996-05-07 Eli Lilly And Company Benzothiophenes to inhibit leukotrienes
EP0842169B1 (en) * 1995-06-26 2001-01-03 Eli Lilly And Company Benzothiophene compounds
ID24978A (id) * 1997-11-14 2000-08-31 Lilly Co Eli 2-ARYL-3-AROYLBENZO (b) THIOPHENES BERGUNA UNTUK PENGOBATAN SINDROM DEPRIVASI ESTROGEN

Also Published As

Publication number Publication date
HUP0004413A2 (hu) 2001-08-28
EP0920863B1 (en) 2003-07-09
ID24978A (id) 2000-08-31
CN1278812A (zh) 2001-01-03
WO1999025706A1 (en) 1999-05-27
IL135509A0 (en) 2001-05-20
AU748394B2 (en) 2002-06-06
US6156786A (en) 2000-12-05
CA2309824A1 (en) 1999-05-27
PL340432A1 (en) 2001-02-12
EA200000520A1 (ru) 2000-10-30
AU1385899A (en) 1999-06-07
ZA9810215B (en) 2000-05-09
ATE244565T1 (de) 2003-07-15
TR200001290T2 (tr) 2000-09-21
DE69816244D1 (de) 2003-08-14
NO20002370L (no) 2000-07-05
NO20002370D0 (no) 2000-05-05
US6403615B1 (en) 2002-06-11
NZ503990A (en) 2002-05-31
JP2001523675A (ja) 2001-11-27
HRP20000287A2 (en) 2000-08-31
HUP0004413A3 (en) 2002-12-28
KR20010031904A (ko) 2001-04-16
EP0920863A1 (en) 1999-06-09

Similar Documents

Publication Publication Date Title
BR9917007A (pt) Moduladores de ccr5
BR9804437A (pt) Compostos para a osteoporose
BR0010555A (pt) Inibidores de neuraminidases
BR0111562A (pt) Análogos de peptìdeo 1 semelhantes ao glucagon
MX9702865A (es) Agentes estrogenicos.
BR0009814A (pt) Processo para tratar de uma doença associada com o receptor-beta estrogênico
UA66750C2 (en) Substituted 1-phenylpirazole 3-carboxamides, a method for the preparation thereof and intermediary compounds, pharmaceutical composition having affinity to neurotensin receptors
BR9813996A (pt) 2-arilbenzo[b]tiofenos úteis para o tratamento de sìndrome da privação de estrogênio
ATE221879T1 (de) Kristalline paclitaxel hydrate
BR9910573A (pt) Compostos antipicornavirais, preparação e uso dos mesmos
WO2001045678A3 (de) Arzneimittel, verfahren zu dessen herstellung und dessen verwendung
BR9812780A (pt) 2-aril-3-aroilbenzo[b]tiofenos úteis para o tratamento de sìndrome da perda de estrogênio
WO2002042271A3 (en) Biphenylcarboxamides useful as lipid lowering agents
BR9712705A (pt) Composição para o tratamento da asma, contendo loratadina e um descongestionante
NO20014241D0 (no) C16-umettede FP-selektive prostaglandinanaloger
SE9801494D0 (sv) Novel use
BR9712307A (pt) Pirazolinonas para o tratamento de potência enfraquecida
BR9814199A (pt) Utilização dos quetólidos para prevenir as complicações trombóticas arteriais ligadas à aterosclerose
BR0007183A (pt) Isonipectoamidas para o tratamento de distúrbios mediados por integrina
BR9813897A (pt) Derivados de bifenila como farmacêuticos
PT869785E (pt) 4-hidroxicumarina-3-carboxamidas para o tratamento de diabetes mellitus nao insulinodependente
BR0007897A (pt) Uso de derivados anticonvulsivantes para otratamento de bulimia nervosa
BR0016781A (pt) Bases de 1-naftol e 2-naftol - mannich substituìdas
BR9909029A (pt) Estabilização de poliisocianatos orgânicos
AU7028798A (en) Use of 2-methylthiazolidine-2,4-dicarboxylic acid as mucolytic agent

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08H Application fees: decision cancelled [chapter 8.8 patent gazette]

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1771 DE 20041214 POR TER SIDO APRESENTADA PAPELETA DE ESCLARECIMENTO.

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6O,7O,8O E 9O ANUIDADES

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1909 DE 07/08/2007.